Cover art for Revolution Medicines Drug Targets 'Undruggable' Cancer

Revolution Medicines Drug Targets 'Undruggable' Cancer

Revolution Medicines' Rasonque, the first drug to target RAS-addicted cancers, generated $198 million in five weeks.

7 cards · 1m 10s · tap to begin

From · · · 1m 10s

Revolution Medicines Drug Targets 'Undruggable' Cancer

Revolution Medicines' Rasonque, the first drug to target RAS-addicted cancers, generated $198 million in five weeks.

In brief

Revolution Medicines' Rasonque, the first drug to target RAS-addicted cancers, generated $198 million in five weeks. Revolution Medicines' Rasonque achieved the strongest oncology drug launch in history with $198 million revenue in five weeks. Originally reported by The Motley Fool.

Rasonque Approval

Scientists in a lab review a sample.

Revolution Medicines earned approval for Rasonque, a medicine for pancreatic cancer targeting RAS-addicted cancers.

Strong Launch

Rasonque generated $198 million in five weeks, marking the strongest oncology drug launch on record.

Clinical Results

Rasonque led to a median overall survival of 13.2 months versus 6.7 months with chemotherapy in Phase 3 trials.

RAS-Addicted Cancers

RAS-addicted cancers account for 20% to 30% of all human cancers, making Rasonque's target historically undruggable.

Pipeline Progress

Revolution Medicines has eight Phase 3 clinical trials, including two investigational medicines, zoldonrasib and elironrasib.

Market Reaction

Shares rose 100% this year after Rasonque's approval, but declined 29% since launch despite strong sales.

Valuation Justification

The company's $34.8 billion market cap is justified by potential $3 billion in next year's revenue and 11.6x sales valuation.

The takeaway

Revolution Medicines' Rasonque achieved the strongest oncology drug launch in history with $198 million revenue in five weeks.

Read the original on The Motley Fool

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on revolution medicines and related topics.